This section is password-protected. Please use the group password to access the documents.
Debiopharm and EORTC announce a collaboration to investigate Triptorelin for treatment of Salivary Gland Cancers 13/01/2016
DATECAN initiative publishes Guidelines for time-to-event end point definitions in breast cancer trials 19/05/2015
EORTC trial evaluates androgen deprivation therapy for patients with recurrent / metastatic androgen receptor expressing 10/02/2015
EORTC and DAHANCA launch trial for patients with locally advanced squamous cell carcinoma of the head and neck 04/06/2014
EORTC trial opens for patients with differentiated or medullary thyroid cancer progressing after first line therapy 20/05/2014
EORTC head & neck cancer trial shows assessing HRQOL is valuable to both patients and their doctors 20/11/2013
Addressing treatment resistance in patients with squamous cell carcinoma of head and neck with Pr. Machiels and Blanpain 13/09/2013